Short indobufen tablets are platelet aggregation inhibitors
Indobufen Tablets can exert anti-platelet aggregation effects by inhibiting platelet cyclooxygenase, as well as inhibiting platelet aggregation induced by platelet-activating factor, and reducing platelet adhesion.
Indobufen Tablets are mainly used for the treatment of venous thrombosis caused by atherosclerosis, ischemic cerebrovascular lesions, ischemic cardiovascular lesions, and can also be used in hemodialysis to prevent the formation of blood clots.
It should be noted that the use of Indobufen Tablets is prohibited for those who are allergic to any components of this drug, pregnant women, lactating women, patients with congenital or acquired bleeding disorders, and some patients may experience dyspepsia, headache, dizziness, abdominal pain, constipation, gingival bleeding, hematuria, and other adverse reactions, and if the discomfort is more serious, they should seek medical attention in a timely manner.
Patients should follow the doctor’s instructions to use indobufen tablets, not self-medication, so as not to affect the condition.